Tavotek Biotherapeutics Snares $20M in Series A

22 Mar, 2021

Tavotek Biotherapeutics Snares $20M in Series A
Photo by Sander Crombach on Unsplash

– Tavotek Biotherapeutics from Lower Gwynedd, Pennsylvania, has raised over $20M in financing in the preceding two months.
YuanBio Venture Capital led the A1 finance round followed by Oriza Holdings, Ming BioVentures, and New Alliance Capital.
– Series A2 financing was jointly invested by GF Xinde, CTS Capital, and Lanhu Capital.

North America Pharmaceuticals
Crunchbase icon

Content report

The following text will be sent to our editors: